Search hospitals > Illinois > O'Fallon

HSHS Saint Elizabeth's Hospital

Claim this profile
O'Fallon, Illinois 62269
Global Leader in Cancer
Conducts research for Breast Cancer
Conducts research for Plasma Cell Neoplasms
Conducts research for Multiple Myeloma
Conducts research for Squamous Cell Carcinoma
13 reported clinical trials
1 medical researcher
Photo of HSHS Saint Elizabeth's Hospital in O'FallonPhoto of HSHS Saint Elizabeth's Hospital in O'FallonPhoto of HSHS Saint Elizabeth's Hospital in O'Fallon

Summary

HSHS Saint Elizabeth's Hospital is a medical facility located in O'Fallon, Illinois. This center is recognized for care of Cancer, Breast Cancer, Plasma Cell Neoplasms, Multiple Myeloma, Squamous Cell Carcinoma and other specialties. HSHS Saint Elizabeth's Hospital is involved with conducting 13 clinical trials across 96 conditions. There are 1 research doctors associated with this hospital, such as Bryan A. Faller.

Area of expertise

1Cancer
Global Leader
HSHS Saint Elizabeth's Hospital has run 14 trials for Cancer. Some of their research focus areas include:
Stage I
Stage IV
Stage II
2Breast Cancer
HSHS Saint Elizabeth's Hospital has run 6 trials for Breast Cancer. Some of their research focus areas include:
HER2 positive
Stage II
Stage I

Top PIs

Clinical Trials running at HSHS Saint Elizabeth's Hospital

Non-Small Cell Lung Cancer
Squamous Cell Carcinoma
Cancer
Multiple Myeloma
Breast Cancer
Cutaneous Melanoma
Lung Cancer
Gallbladder Cancer
Oropharyngeal Carcinoma
Melanoma
Image of trial facility.

Osimertinib

for Non-Small Cell Lung Cancer

This phase II trial studies how well osimertinib works in treating patients with non-small cell lung cancer with EGFR exon 20 insertion mutation that is stage IIIB-IV or has come back (recurrent). Osimertinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
Recruiting1 award Phase 242 criteria
Image of trial facility.

Radiation + Immunotherapy

for Non-Small Cell Lung Cancer

This trial studies the side effects of radiation therapy followed by atezolizumab in treating patients with stage II or III non-small cell lung cancer. Hyperfractionated radiation therapy delivers smaller doses of radiation therapy over time and may kill more tumor cells and have fewer side effects. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. The purpose of this study is to test the safety and effectiveness of radiation therapy followed by atezolizumab and find out what side effects, if any, it has on patient's non-small cell lung cancer.
Recruiting1 award Phase 239 criteria
Image of trial facility.

Genetic Testing

for Early-Stage Lung Cancer

This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at HSHS Saint Elizabeth's Hospital?
HSHS Saint Elizabeth's Hospital is a medical facility located in O'Fallon, Illinois. This center is recognized for care of Cancer, Breast Cancer, Plasma Cell Neoplasms, Multiple Myeloma, Squamous Cell Carcinoma and other specialties. HSHS Saint Elizabeth's Hospital is involved with conducting 13 clinical trials across 96 conditions. There are 1 research doctors associated with this hospital, such as Bryan A. Faller.